Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 30, 2025International Journal of Research in Medical SciencesOpen Access

Prompt diagnosis and treatment of cutaneous mucormycosis: a challenging complication in post-renal transplant patients

View Full Paper
Ask AI
Bookmark
Share

Authors

KSK. N. SinghAGAnkit GroverSGSandeep Guleria

Discussion

Loading...

Member takes

Overview

Case report highlights successful management of cutaneous mucormycosis in a renal transplant patient, suggesting isavuconazole as an effective alternative.

Key Points

  • Prompt diagnosis and treatment of cutaneous mucormycosis stabilized the patient's condition and improved renal function.
  • The patient was treated with liposomal amphotericin B and isavuconazole, along with surgical debridement, leading to good outcomes.
  • Maintaining treatment with isavuconazole shows promise for managing mucormycosis in patients with renal impairment.
  • The patient's follow-up revealed a creatinine level of 1.6 mg/dl, indicating improved renal function one month post-treatment.

Cite This Study

Singh et al. (2025) studied this question.

synapsesocial.com/papers/68dc262a8a7d58c25ebb3613https://doi.org/10.18203/2320-6012.ijrms20253204
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1A Case of Mucormycosis Postrenal Transplant Masquerading Renal Cortical Necrosis2026
  2. 2Fatal Pulmonary Mucormycosis in a Renal Transplant Recipient: A Missed Opportunistic Infection2026
  3. 3A69-17 Pulmonary Mucormycosis in a Stable Post-Hematopoietic Stem Cell Transplant Patient: A Diagnostic Challenge2026
  4. 4The Unnoticed Threat: Clinical Characteristics, Risk Factors, and Outcome of Mucormycosis in Solid Organ Transplantation2025
  5. 5Local amphotericin B for a neglected Rhizopus microsporus necrotizing soft tissue infection following crush syndrome: a case report2026